Search
for
Sort by
Research 31–60 of 95
- Hypertrichosis of the pinnae in a patient using panitumumab
- PRIDE syndrome with lumbosacral hypertrichosis
- Index
- Spironolactone, a Classic Potassium-Sparing Diuretic, Reduces Survivin Expression and Chemosensitizes Cancer Cells to Non-DNA-Damaging Anticancer Drugs
- Chemotherapy and Cutaneous Drug Reactions
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Alopecia in Association with Malignancy: A Review
- Drug eruptions in dermatology
- Dermatologic Adverse Events from Cancer Treatments
- Corrective and Restorative Dermatology in Cancer Survivors: An Urgent Unmet Need!
- Drug-Induced Skin, Nail and Hair Disorders
- Inhibition of β-catenin signalling in dermal fibroblasts enhances hair follicle regeneration during wound healing
- Hair disorders in patients with cancer
- Drug-induced acne
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors
- Approach to the Management of Patients With Hidradenitis Suppurativa: A Consensus Document
- Interventions for female pattern hair loss
- Cetuximab-Associated Elongation of the Eyelashes
- A Case of Cicatricial Alopecia Associated with Erlotinib
- Regulation of Semaphorin3A in the process of cutaneous wound healing
- Protective cardiovascular and renal actions of vitamin D and estrogen
- Lifestyle Drugs
- Evaluation of ischemia-modified albumin level and parameters related with oxidative stress in early onset androgenetic alopecia
- Adult Acne
- Periungual lesions secondary to chemotherapy with docetaxel
- Microneedles in Improving Skin Appearance and Enhanced Delivery of Cosmeceuticals
- General Dermatology
- Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability”